Foetal-maternal alloimmunizations in the south east area of the Venice province;Alloimmunizzazioni feto-materne nel Sud-Est del Veneto

Minerva Ginecologica

Volumn 54, Issue 4, 2002, Pages 333-338

  Gessoni, G ^a,d   Valverde, S ^b   Giacomini, A ^b   Antico, F ^b   Salvadego, M ^a   Arreghini, N ^c   De Fusco, G ^c   Fezzi, M ^c   Marchiori, G ^c   Manoni, F ^b  

^a USL 14 Chioggia (VE)   (Italy)

^b Serv di Medicina di Laboratorio A

^c USL 12 Veneziana   (Italy)

^d Centro Trasfusionale Ospedale Civile   (Italy)

Author keywords

Hemoragic disease of newborn, diagnosis; Hemorragic disease or newborn, prevention and control; Rh Hr blood group system Blood transfusion, intrauterine

Indexed keywords

RHESUS D ANTIBODY;

ARTICLE; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; COOMBS TEST; FEMALE; FETOMATERNAL TRANSFUSION; FETUS BLOOD; HUMAN; IMMUNOLOGY; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; RHESUS ISOIMMUNIZATION;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; COOMBS' TEST; ERYTHROBLASTOSIS, FETAL; FEMALE; FETAL BLOOD; FETOMATERNAL TRANSFUSION; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 0036677057     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Strohm P. Hemolytic disease of fetus and new-born. In: Rudmann S, editor. Texbook of blood banking and transfusion medicine. Philadelphia: WB Saunders & Co, 1995:436-63.
2. Sebring E, Polesky H. Foetal maternal haemorrhage: Incidence risk factors, time of occurrence and clinical effects. Transfusion 1990;30:333-8.
3. rd edition. Miami: Montgomery Scientific Publications, 1985:571-98.
4. Turgeon M. Fundamental of Immunohematology. Chapter 11. Hemolytic disease of the newborn. Philadelphia: William & Wilkins 1995:257-78.
5. Garner S, Devenish A, Barber H, Contreras M. The importance of monitoring enzyme only red cells antibodies during pregnancy. Vox Sanguinis 1991;61:219-20.
6. Urbaniak S. Consensus conference on anti-D prophylaxis. Transfusion 1998;38:87-99.
7. The Royal College of Physicians of Edimburgh, The Royal College of Obstetricians and Gynaecologists UK. Statement from the consensus conference on anti-D prophylaxis. Vox Sanguinis 1998;74:127-8.
8. th edition. Bethesda: AABB Press, 2000.
9. Bowman J. Maternal blood groups immunisation. In: Creasy R, Reesnik R, editors. Maternal and fetal medicine: principles and practice. Philadelphia: Sanders & Co, 1994:711-43.
10. British Committee for Standard in Haematology. Guidelines for blood grouping and red cell antibody testing during pregnancy. Transf Med 1996;6:71-4.
11. Chambers L, Luban N. Neonatal and intrauterine transfusion. In: Nomitz P, editor. Transfusion therapy: Clinical priciples and practice. Bethesda: AABB Press, 1999:299-312.
12. Alverson D, Izquedo L. Hemolytic disease of the newborn: Treatment and prevention. In: Ross E, Simon T, Moss G, Gould S, editors. Principles of transfusion medicine. Baltimore: Williams & Wilkins, 1996:127-40.
13. Heddle N, Klama L, Frassetto R, Hosky P, Leaman B. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993;33:217-20.
14. Giblett E. Blood group antibodies causing haemolytic disease of the new-born. Clin Obstet Gynaecol 1964; 7:1044-8.
15. Kornstadt L. New case of irregular blood group antibodies other than anti-D in pregnancy, frequence and clinical significance. Acta Obstet Gynecol Scand 1982;15:31-7.
16. Hughes R, Craig J, Murphy W, Greer I. Causes and clinical consequences of Rhesus (D) haemolytic disease of the new-born: a study of a Scottish population 1985-1990. Br J Obstet Gynaecol 1994;101:297-300.
17. Moncharmont P, Jouron-Dupraz F, Vignal M, Gigal D, Meyer F, Debeaux P. Haemolytic disease of the new-born infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience. Arch Gynecol Obstet 1991;248:175-80.
18. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the new-born: a 12 years study in central Sweden. Acta Obstet Gynecol Scand 1995;74:687-92.
19. Judd J, Steiner A, Negent C. Appropriate serological testing in pregnancy. Vox Sanguinis 1992;63:293-6.
20. Carreras L, Castro R. Complement is not activated in ABO haemolytic disease of the new-born: Further support. Vox Sanguinis 1990;58:231-3.
21. Noble A, Poole G, Anderson N, Lucas G, Hadley A. Predicting the severity of haemolytic disease of the new-born an assessment of the clinical usefulness of the chemiluminescenze test. Br J Haematol 1990;30:175-83.
22. Judd W, Luban N, Ness P, Silberstein L, Stroup M, Widmann F. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, new-born, infant and obstetric patient. Transfusion 1990;30:175-83.
23. th edition. London: Blackwell Science, 1997:414-67.
24. Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perimnatol 1997;21: 39-44.
25. nd edition. Philadelphia: Saunders & Co, 2000:321-36.
26. Grundbacher F. The etiology of ABO haemolytic disease of the newborn. Transfusion 1980;20:563-8.
27. Toy P, Reid M, Yeap H, Black D. Prevalence of ABO maternal-infant incompatibility in Asians, blacks, hispanicus and caucasians. Vox Sanguinis 1988;54:181-3.
28. Palfi M, Gunnarson C. The frequency of anti-C + anti-G in the absence of anti-D in alloimmunized pregnancies. Transf Med 2001;11:207-10.
29. Stanworth P, Fleetwood M, De Silva M. Severe haemolytic disease of the newborn due to anti Jsb. Vox Sanguinis 2001;81:134-6.
30. Decreto del Ministro della Sanità del 10/09/1998. Gazzetta Ufficiale della Repubblica Italiana del 20 Ottobre 1998, n. 245, pp. 24-29.